Robert McClure
Family Medicine · Caneyville, KYNPI 1447253786
Payments from drug & device makers
Across 195 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$473
- GSK$415
- Merck$264
- AbbVie$254
- Pfizer$247
- Lilly USA, LLC$246
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,991100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $473 |
| GSK | 34 | $415 |
| Merck | 17 | $264 |
| AbbVie(2 entities) | 13 | $254 |
| Pfizer | 17 | $247 |
| Lilly USA, LLC | 17 | $246 |
| Novo Nordisk | 14 | $242 |
| Sanofi-aventis U.S. LLC | 10 | $140 |
| Amarin Pharma, Inc. | 6 | $109 |
| Boehringer Ingelheim | 5 | $78 |
| Amgen | 5 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $54 |
| Ultragenyx Pharmaceutical Inc. | 2 | $46 |
| Mylan Specialty L.p. | 3 | $44 |
| Bayer | 3 | $44 |
| Exact Sciences | 2 | $32 |
| Medtronic | 1 | $31 |
| Astellas Pharma US Inc | 2 | $28 |
| Gilead | 1 | $24 |
| Corcept Therapeutics | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Metacel Pharmaceuticals LLC | 1 | $8 |
How this compares
$3,003 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 157 | $136,443 |
| EliquisApixaban | 160 | $135,183 |
| OzempicSemaglutide | 110 | $115,827 |
| FarxigaDapagliflozin Propanediol | 116 | $82,511 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 88 | $79,761 |
| TrulicityDulaglutide | 53 | $58,030 |
| JanuviaSitagliptin Phosphate | 57 | $51,082 |
| MounjaroTirzepatide | 29 | $30,515 |
| XareltoRivaroxaban | 41 | $30,146 |
| LinzessLinaclotide | 49 | $26,709 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $20,877 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $20,822 |
| EntrestoSacubitril/Valsartan | 28 | $20,683 |
| XolairOmalizumab | 12 | $16,671 |
| Spiriva HandihalerTiotropium Bromide | 29 | $14,809 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $78 | $163,883207 claims |
| PfizerEliquis | $247 | $135,183160 claims |
| Novo NordiskOzempic, Levemir | $242 | $122,267129 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $415 | $106,200146 claims |
| AstraZenecaFarxiga, Brilinta | $473 | $90,469128 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $246 | $88,54582 claims |
| MerckJanuvia, Asmanex | $264 | $53,11169 claims |
| Johnson & JohnsonXarelto | $19 | $30,14641 claims |
| AbbVieLinzess | $254 | $26,70949 claims |
| NovartisEntresto | $13 | $20,68328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Caneyville
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.